PGC-1α Promotes Nitric Oxide Antioxidant Defenses and Inhibits FOXO Signaling Against Cardiac Cachexia in Mice
- 30 April 2011
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 178 (4), 1738-1748
- https://doi.org/10.1016/j.ajpath.2011.01.005
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AR050429)
- American Heart Association, Mid-Atlantic Affiliate (0555426U)
This publication has 50 references indexed in Scilit:
- PGC-1α Regulates Expression of Myocardial Mitochondrial Antioxidants and Myocardial Oxidative Stress After Chronic Systolic OverloadAntioxidants and Redox Signaling, 2010
- p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wastingAmerican Journal of Physiology-Cell Physiology, 2010
- PGC-1α plays a functional role in exercise-induced mitochondrial biogenesis and angiogenesis but not fiber-type transformation in mouse skeletal muscleAmerican Journal of Physiology-Cell Physiology, 2010
- Genetic Deletion of Myostatin From the Heart Prevents Skeletal Muscle Atrophy in Heart FailureCirculation, 2010
- Fiber Type-Specific Nitric Oxide Protects Oxidative Myofibers against Cachectic StimuliPLOS ONE, 2008
- NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOSJCI Insight, 2007
- Functional overload attenuates plantaris atrophy in tumor-bearing ratsBMC Cancer, 2007
- Oxidative Phenotype Protects Myofibers from Pathological Insults Induced by Chronic Heart Failure in MiceThe American Journal of Pathology, 2007
- PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcriptionProceedings of the National Academy of Sciences of the United States of America, 2006
- Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibresNature, 2002